Home › IPO-bound Aduro snags Big Pharma cancer immunotherapy deal
 

Keywords :   


IPO-bound Aduro snags Big Pharma cancer immunotherapy deal

2015-03-30 11:22:11| Biotech - Topix.net

Tiny Aduro Biotech Inc. hopes to put the STING on cancer with a potential $750 million deal between the Berkeley company and drug giant Novartis AG. The deal centers on experimental synthetic small molecules, developed by Aduro, that could be the latest weapon in the hot field of cancer immunotherapy.

Tags: big deal cancer pharma

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Hurricane Rafael Update Statement
06.11Summary for Hurricane Rafael (AT3/AL182024)
06.11Warning millions will struggle to pay water bill rises
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
More »